EUROLAB
iso-10993-15-toxicokinetic-study
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

ISO 10993-15 Toxicokinetic Study Laboratory Testing Service: A Comprehensive Guide

The ISO 10993-15 standard is part of the ISO 10993 series, which provides guidelines for the biological evaluation of medical devices. The standard focuses on toxicokinetic studies, which are essential in assessing the biocompatibility and safety of medical devices.

Legal and Regulatory Framework

The use of medical devices is governed by various laws and regulations worldwide. In the European Union (EU), the Medical Devices Regulation (MDR) 2017/745 establishes the requirements for medical device manufacturers to demonstrate the conformity of their products with EU law. The ISO 10993-15 standard is referenced in the MDR as one of the essential standards for assessing the biocompatibility of medical devices.

In the United States, the FDA regulates medical devices under the Federal Food, Drug, and Cosmetic Act (FDC). The FDA recommends the use of the ISO 10993 series for assessing the biocompatibility of medical devices. Similarly, in other countries like Canada, Australia, and Japan, national regulations reference or incorporate international standards like ISO 10993-15.

International and National Standards

The following are some of the relevant international and national standards that apply to ISO 10993-15 Toxicokinetic Study testing:

  • ISO 10993-1:2018 (Biological evaluation of medical devices -- Part 1: Evaluation and risk assessment)

  • ISO 10993-15:2015 (Biological evaluation of medical devices -- Part 15: Anaerobic extraction test for constituents and simulation fluid tests)

  • EN ISO 10993-1:2014 (Biological evaluation of medical devices -- Part 1: Evaluation and risk assessment)

  • TSE ISO 10993-1:2016 (Biological evaluation of medical devices -- Part 1: Evaluation and risk assessment)

    • Standard Development Organizations

    The International Organization for Standardization (ISO) is responsible for developing and maintaining the ISO 10993 series. The European Committee for Standardization (CEN), the American Society for Testing and Materials (ASTM), and other national standards organizations contribute to the development of these standards.

    Standard Evolution and Updates

    Standards evolve over time as new scientific evidence emerges, and regulatory requirements change. Standards are reviewed, revised, or withdrawn periodically to ensure they remain relevant and effective. The ISO 10993 series is regularly updated to reflect advances in medical device technology and regulatory requirements.

    Industry-Specific Compliance Requirements

    Compliance with the ISO 10993-15 standard varies depending on the industry and type of medical device. For example:

  • Class I medical devices (e.g., bandages, examination gloves) may not require extensive biocompatibility testing.

  • Class IIa medical devices (e.g., implantable cardioverter-defibrillators, surgical instruments) may require more comprehensive biocompatibility testing.

  • Class III medical devices (e.g., implantable pacemakers, hip replacement components) typically require the most extensive biocompatibility testing.

    • The ISO 10993-15 standard is essential for assessing the biocompatibility of medical devices. The purpose of this standard is to provide a framework for evaluating the potential toxicity and genotoxicity of constituents extracted from medical devices under conditions that mimic human exposure.

    Why This Test Is Needed

    Toxicokinetic studies are necessary to assess the safety of medical devices by evaluating their potential impact on human health. These studies help identify potential hazards associated with device materials, thereby ensuring patient safety and minimizing liability risks for manufacturers.

    Consequences of Not Performing This Test

    Failure to conduct ISO 10993-15 testing can lead to:

  • Inadequate assessment of biocompatibility

  • Lack of confidence in product safety

  • Potential recalls or withdrawals of products from the market

  • Regulatory non-compliance and associated fines

  • Damage to a companys reputation and customer trust

    • Industries Requiring This Testing

    The ISO 10993-15 standard applies to various industries, including:

  • Medical device manufacturers (e.g., orthopedic implants, cardiovascular devices)

  • Pharmaceutical companies developing medical products with potential device applications

  • Research institutions studying biocompatibility and safety of materials in medical devices

    • Risk Factors and Safety Implications

    The ISO 10993-15 standard is designed to mitigate risks associated with medical device materials. Failure to conduct this testing may expose patients to potential health hazards, such as:

  • Toxicity (e.g., carcinogenic, mutagenic effects)

  • Immunotoxicity

  • Local tissue irritation or inflammation

    • Quality Assurance and Quality Control Aspects

    Eurolab ensures the highest quality in performing ISO 10993-15 testing through:

  • Regular calibration and maintenance of equipment

  • Training and certification of personnel

  • Implementation of quality management systems (QMS) and procedures

  • Use of validated methods and protocols

  • Continuous monitoring and improvement of testing processes

    • Test Methodologies

    The ISO 10993-15 standard describes various test methodologies for assessing the biocompatibility of medical devices, including:

  • Anaerobic extraction tests

  • Simulation fluid tests

  • Cell culture assays (e.g., cytotoxicity, genotoxicity)

  • Histopathological evaluation

    • Toxicokinetic Study Design

    Eurolabs toxicokinetic study design ensures that each test is tailored to the specific requirements of the medical device. Our expert team will work closely with clients to:

  • Define testing objectives and scope

  • Select relevant cell lines or tissues for assessment

  • Develop a customized testing protocol

    • Toxicokinetic Study Implementation

    Eurolabs experienced scientists and technicians conduct the ISO 10993-15 testing in accordance with established protocols. Our state-of-the-art facilities and equipment ensure accurate and reliable results.

    Toxicokinetic Study Interpretation

    Our team of experts will interpret the test results, providing a comprehensive report on the biocompatibility of the medical device. We will:

  • Analyze data from various assays

  • Compare results with established acceptance criteria

  • Draw conclusions regarding potential hazards

    • Compliance requirements for ISO 10993-15 testing vary depending on the industry and type of medical device. For example:

  • Class I medical devices: May not require extensive biocompatibility testing.

  • Class IIa medical devices: May require more comprehensive biocompatibility testing.

  • Class III medical devices: Typically require the most extensive biocompatibility testing.

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    Test Report

    Our test report will provide a detailed summary of the biocompatibility assessment, including:

  • Test objectives and scope

  • Methodologies used for each assay

  • Results from various tests, including cell culture assays and histopathological evaluation

  • Conclusions regarding potential hazards associated with device materials

    • Acceptance Criteria

    Eurolabs acceptance criteria ensure that test results are compared against established standards. Our team will:

  • Analyze data from various assays

  • Compare results with established acceptance criteria

  • Draw conclusions regarding potential hazards

    • Quality Control and Assurance

    Eurolab ensures the highest quality in performing ISO 10993-15 testing through regular calibration and maintenance of equipment, training and certification of personnel, implementation of QMS and procedures, use of validated methods and protocols, and continuous monitoring and improvement of testing processes.

    Compliance requirements for ISO 10993-15 testing vary depending on the industry and type of medical device. For example:

  • Class I medical devices: May not require extensive biocompatibility testing.

  • Class IIa medical devices: May require more comprehensive biocompatibility testing.

  • Class III medical devices: Typically require the most extensive biocompatibility testing.

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    Test Methodologies

    The ISO 10993-15 standard describes various test methodologies for assessing the biocompatibility of medical devices, including:

  • Anaerobic extraction tests

  • Simulation fluid tests

  • Cell culture assays (e.g., cytotoxicity, genotoxicity)

  • Histopathological evaluation

    • Toxicokinetic Study Design

    Eurolabs toxicokinetic study design ensures that each test is tailored to the specific requirements of the medical device. Our expert team will work closely with clients to:

  • Define testing objectives and scope

  • Select relevant cell lines or tissues for assessment

  • Develop a customized testing protocol

    • Toxicokinetic Study Implementation

    Eurolabs experienced scientists and technicians conduct the ISO 10993-15 testing in accordance with established protocols. Our state-of-the-art facilities and equipment ensure accurate and reliable results.

    Toxicokinetic Study Interpretation

    Our team of experts will interpret the test results, providing a comprehensive report on the biocompatibility of the medical device. We will:

  • Analyze data from various assays

  • Compare results with established acceptance criteria

  • Draw conclusions regarding potential hazards

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    Industry-Specific Compliance Requirements

    Compliance requirements for ISO 10993-15 testing vary depending on the industry and type of medical device. For example:

  • Class I medical devices: May not require extensive biocompatibility testing.

  • Class IIa medical devices: May require more comprehensive biocompatibility testing.

  • Class III medical devices: Typically require the most extensive biocompatibility testing.

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    References

  • ISO 10993-1:2018 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

  • ISO 10993-2:2006 Biological evaluation of medical devices -- Part 2: Animal welfare requirements

  • ISO 10993-3:2020 Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity, and reproductive toxicity

    • Certifications

    Eurolab is certified to the following standards:

  • ISO 9001:2015 Quality Management System

  • ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories

  • GLP (Good Laboratory Practice)

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    Industry-Specific Compliance Requirements

    Compliance requirements for ISO 10993-15 testing vary depending on the industry and type of medical device. For example:

  • Class I medical devices: May not require extensive biocompatibility testing.

  • Class IIa medical devices: May require more comprehensive biocompatibility testing.

  • Class III medical devices: Typically require the most extensive biocompatibility testing.

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    References

  • ISO 10993-1:2018 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

  • ISO 10993-2:2006 Biological evaluation of medical devices -- Part 2: Animal welfare requirements

  • ISO 10993-3:2020 Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity, and reproductive toxicity

    • Certifications

    Eurolab is certified to the following standards:

  • ISO 9001:2015 Quality Management System

  • ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories

  • GLP (Good Laboratory Practice)

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    Industry-Specific Compliance Requirements

    Compliance requirements for ISO 10993-15 testing vary depending on the industry and type of medical device. For example:

  • Class I medical devices: May not require extensive biocompatibility testing.

  • Class IIa medical devices: May require more comprehensive biocompatibility testing.

  • Class III medical devices: Typically require the most extensive biocompatibility testing.

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    References

  • ISO 10993-1:2018 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

  • ISO 10993-2:2006 Biological evaluation of medical devices -- Part 2: Animal welfare requirements

  • ISO 10993-3:2020 Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity, and reproductive toxicity

    • Certifications

    Eurolab is certified to the following standards:

  • ISO 9001:2015 Quality Management System

  • ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories

  • GLP (Good Laboratory Practice)

    • Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    ISO 10993-15 Toxicokinetic Study Laboratory Testing Service: A Comprehensive Guide

    This guide provides an overview of the ISO 10993-15 standard and its application to medical devices. It highlights the importance of biocompatibility testing in ensuring the safety and efficacy of medical devices, and discusses the key principles and requirements for conducting toxicokinetic studies.

    Table of Contents

    1. Introduction

    2. Overview of ISO 10993-15

    3. Principles of Biocompatibility Testing

    4. Toxicokinetic Studies

    5. Industry-Specific Compliance Requirements

    6. References

    7. Certifications

    Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    ISO 10993-15 Toxicokinetic Study Laboratory Testing Service: A Comprehensive Guide

    This guide provides an overview of the ISO 10993-15 standard and its application to medical devices. It highlights the importance of biocompatibility testing in ensuring the safety and efficacy of medical devices, and discusses the key principles and requirements for conducting toxicokinetic studies.

    Table of Contents

    1. Introduction

    2. Overview of ISO 10993-15

    3. Principles of Biocompatibility Testing

    4. Toxicokinetic Studies

    5. Industry-Specific Compliance Requirements

    6. References

    7. Certifications

    Conclusion

    The ISO 10993-15 standard is essential for assessing the biocompatibility and safety of medical devices. Failure to conduct this testing can lead to inadequate assessment, regulatory non-compliance, and potential health hazards for patients. Eurolab provides comprehensive services for toxicokinetic studies, ensuring that clients meet industry-specific compliance requirements while minimizing risks associated with device materials.

    ISO 10993-15 Toxicokinetic Study Laboratory Testing Service: A Comprehensive Guide

    This guide provides an overview of the ISO 10993-15 standard and its application to medical devices. It highlights the importance of biocompatibility testing in ensuring the safety and efficacy of medical devices, and discusses the key principles and requirements for conducting toxicokinetic studies.

    Table of Contents

    1. Introduction

    2. Overview of ISO 10993-15

    3. Principles of Biocompatibility Testing

    4. Toxicokinetic Studies

    5. Industry-Specific Compliance Requirements

    6. References

    7. Certifications

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers